| Literature DB >> 26933952 |
Cassandra Kruczek1, Kameswara Rao Kottapalli2, Sharmila Dissanaike1, Nyaradzo Dzvova3, John A Griswold1, Jane A Colmer-Hamood3,4, Abdul N Hamood1,3.
Abstract
Pseudomonas aeruginosa is a Gram-negative opportunistic pathogen that causes serious infections in immunocompromised hosts including severely burned patients. After multiplying within the burn wound, P. aeruginosa translocate into the bloodstream causing bacterial sepsis frequently leading to organ dysfunction and septic shock. Although the pathogenesis of P. aeruginosa infection of thermally-injured wounds has been extensively analyzed, little is known regarding the ability of P. aeruginosa to adapt and survive within the blood of severely burned patients during systemic infection. To identify such adaptations, transcriptome analyses (RNA-seq) were conducted on P. aeruginosa strain PA14 that was grown in whole blood from a healthy volunteer or three severely burned patients. Compared with growth in blood from healthy volunteers, growth of PA14 in the blood from severely burned patients significantly altered the expression of 2596 genes, with expression of 1060 genes enhanced, while that of 1536 genes was reduced. Genes whose expression was significantly reduced included genes related to quorum sensing, quorum sensing-controlled virulence factors and transport of heme, phosphate, and phosphonate. Genes whose expression was significantly enhanced were related to the type III secretion system, the pyochelin iron-acquisition system, flagellum synthesis, and pyocyanin production. We confirmed changes in expression of many of these genes using qRT-PCR. Although severe burns altered the levels of different blood components in each patient, the growth of PA14 in their blood produced similar changes in the expression of each gene. These results suggest that, in response to changes in the blood of severely burned patients and as part of its survival strategy, P. aeruginosa enhances the expression of certain virulence genes and reduces the expression of others.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26933952 PMCID: PMC4774932 DOI: 10.1371/journal.pone.0149229
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Characteristics of the three burn patients.
| Age (y) | Sex | % TBSA | Burn severity | Source | Time post-injury | |
|---|---|---|---|---|---|---|
| Patient 1 | 28 | Male | 30% | 2nd and 3rd degree | Heat (car fire) | 24 h |
| Patient 2 | 62 | Male | 50% | 2nd and 3rd degree | Heat (flash explosion) | 48 h |
| Patient 3 | 43 | Male | 25% | 2nd degree | Heat (gas explosion) | 72 h |
aPercentage of total body surface area involved in burn
bTime to collection of blood sample
Fig 1Gene Ontology (GO) molecular function terms assigned to the differentially expressed genes.
Genes whose expression was differentially regulated when the bacteria were grown in whole blood from the patients compared to the healthy volunteer were analyzed using PANTHER GO-Slim Molecular Function analysis [42,43]. A total of 4949 GO terms were assigned to the 2348 mapped genes, with 1425 of these being unclassified. The remaining 3524 terms represented enzymatic activity—2269 (A), substrate binding—678 (B), transporter activity—480 (C), and functions related to transcription, translation, and DNA replication—670 (D). Some functions were assigned to more than one category.
QS and QS-controlled genes differentially expressed in PA14 grown in whole blood from severely burned patients.
| Gene | Product name | Pt 1 | Pt 2 | Pt 3 |
|---|---|---|---|---|
| Functional classification(s) // Gene ontology (GO) terms | ||||
| -2 | -2 | -2 | ||
| Transcriptional regulators // Regulation of transcription, DNA-templated; Sequence-specific DNA-binding transcription factor activity | ||||
| // Transcription factor LuxR-like, autoinducer-binding domain | ||||
| -4 | -4 | -4 | ||
| Secreted factors; translation, post-translational modification, degradation; amino acid biosynthesis and metabolism // Proteolysis; metalloendopeptidase activity | ||||
| // Thermolysin metalloprotease (M4) family signature | ||||
| -83 | -71 | -76 | ||
| Secreted factors; translation, post-translational modification, degradation // proteolysis; endopeptidase activity; metalloendopeptidase activity | ||||
| // Peptidase M23A, B-lytic metalloendopeptidase | ||||
| -4 | -4 | -4 | ||
| Transcriptional regulators // Regulation of transcription, DNA-templated; sequence-specific DNA-binding transcription factor activity | ||||
| // Transcription factor LuxR-like, autoinducer-binding domain | ||||
| -12 | -11 | -12 | ||
| Secreted factors // | ||||
| // Alpha/beta hydrolase family | ||||
| -11 | -11 | -11 | ||
| Secreted factors // Metabolic process; carbohydrate metabolic process; lipid glycosylation; transferase activity (hexosyl groups) | ||||
| -3 | -3 | -2 | ||
| Hypothetical, unclassified, unknown // Chemotaxis; phospholipase C activity; hydrolase activity (ester bonds) | ||||
| // Phospholipase C/P1 nuclease domain | ||||
| 5 | 5 | 4 | ||
| Biosynthesis of cofactors, prosthetic groups, and carriers // Metabolic process; secondary metabolite biosynthetic process | ||||
| // Aromatic-ring hydroxylase (flavoprotein monooxygenase) signature; FAD binding domain | ||||
| -2 | -2 | -2 | ||
| Hypothetical, unclassified, unknown; biosynthesis of cofactors, prosthetic groups, and carriers // Metabolic process; secondary metabolite biosynthetic process; lipid biosynthetic process; fatty acid biosynthetic process; catalytic activity; 3-oxoacyl-[acyl-carrier-protein] synthase activity | ||||
| -2 | -2 | -2 | ||
| Hypothetical, unclassified, unknown; biosynthesis of cofactors, prosthetic groups, and carriers // Metabolic process; secondary metabolite biosynthetic process; catalytic activity | ||||
| // Thiolase-like | ||||
| -2 | -2 | -2 | ||
| Hypothetical, unclassified, unknown; biosynthesis of cofactors, prosthetic groups, and carriers // Metabolic process; secondary metabolite biosynthetic process; catalytic activity | ||||
| // AMP-dependent synthetase/ligase | ||||
| Putative enzymes // Metabolic process; asparagine biosynthetic process; asparagine synthase activity (glutamine-hydrolyzing) | ||||
| Putative enzymes // Metabolic process; oxidoreductase activity | ||||
| Secreted factors // Phenazine biosynthetic process; oxidation-reduction process; pyridoxine biosynthetic process; FMN binding; pyridoxamine-phosphate oxidase activity; oxidation-reduction activity, acting on CH-NH2 group | ||||
| 3 | 3 | 4 | ||
| Secreted factors // Biosynthetic process; catalytic activity | ||||
| 4 | 4 | 4 | ||
| Secreted factors // Biosynthetic process | ||||
| 6 | 6 | 6 | ||
| Secreted factors // Metabolic process; isochorismatase activity; catalytic activity | ||||
| 4 | 4 | 4 | ||
| Secreted factors // Aromatic amino acid family biosynthetic process; 3-deoxy-7-phosphoheptulonate synthase activity | ||||
| 3 | 3 | 3 | ||
| Secreted factors // Oxidation-reduction process; pyridoxine biosynthetic process; oxidoreductase activity, acting on the CH-NH2 group; FMN binding; pyridoxamine-phosphate oxidase activity | ||||
| 3 | 3 | 3 | ||
| Secreted factors // Biosynthetic process; catalytic activity | ||||
| -9 | -8 | -7 | ||
| Transcriptional regulators; adaptation, protection // Regulation of transcription, DNA-templated; positive-regulation single-species biofilm formation; negative-regulation of cytolysis in other organism; negative-regulation of elastin catabolism; negative-regulation of cell motility; negative-regulation of secondary metabolism and biosynthesis; quorum sensing; DNA binding | ||||
| // Lambda repressor-like, DNA-binding domain | ||||
| -4 | -3 | -3 | ||
| Transcriptional regulators // No GO terms listed | ||||
| // | ||||
| -2 | -2 | -2 | ||
| Transcriptional regulators; translation, post-translational modification, degradation; adaptation, protection // Regulation of carbohydrate metabolic process; mRNA catabolic process; RNA binding | ||||
| -3 | -3 | -4 | ||
| Transcriptional regulators // Regulation of transcription, DNA-templated; sequence-specific DNA binding transcription factor activity | ||||
| // Signal transduction response regulator, C-terminal effector; LuxR bacterial regulatory protein HTH signature |
aProduct names, functional classification(s), gene ontology terms, pathways, and functional predictions for PA14 genes were obtained from the MGH-ParaBioSys:NHLBI Program for Genomic Applications, Massachusetts General Hospital and Harvard Medical School, Boston, MA (http://pga.mgh.harvard.edu; accessed 10Nov2015) [45] made available by the Pseudomonas Genome Database (http://www.pseudomonas.com/; accessed 10Nov2015) [44].
bGene expression within PA14 grown in whole blood from the three severely burned patients (Pt) was compared with expression when PA14 was grown in whole blood from a healthy volunteer.
cGenes found in operons: pqsA/pqsB/pqsC; phzG1/phzF1/phzE1/phzD1/phzC1; phzG2/phzF2.
Fig 2Growth of PA14 in whole blood from a severely burned patient significantly repressed expression of QS and QS-controlled genes.
RNA extracted from PA14 grown in whole blood from Patient 3 or the healthy volunteer was examined in qRT-PCR as described in Methods. A. Level of expression of lasI, lasR, and lasB. B. Level of expression of rhlI, rhlR, and rhlA. Values in A and B represent the average of triplicate PCR experiments conducted on three independently obtained RNA preparations ±SEM; *P <0.05, **P<0.01, ****P <0.0001.
Comparison of QS gene expression in healthy human blood to that in LB broth.
| Gene | Protein product | Healthy volunteer: LB broth | Average of Burn Pts: Healthy volunteer |
|---|---|---|---|
| LasR | 1 | -2 | |
| LasA | -3 | -77 | |
| LasB | 1 | -4 | |
| RhlR | 1 | -4 | |
| RhlA | 1 | -12 | |
| RhlB | -2 | -11 | |
| PlcB | 1 | -3 | |
| PqsE | -3 | 1 | |
| PqsD | -3 | 1 | |
| PqsC | -4 | -2 | |
| PqsB | -3 | -2 | |
| PqsA | 1 | -2 | |
| Potential phenazine-modifying enzyme | -2 | 4 | |
| Hypothetical protein | -23 | 4 | |
| PhzG | -12 | 6 | |
| PhzF | -12 | 4 | |
| PhzE | -12 | 3 | |
| PhzD | -9 | 3 | |
| PhzC | -4 | 3 | |
| Pyridoxamine 5'-phosphate oxidase | -25 | 3 | |
| Phenazine biosynthesis protein | -12 | 4 | |
| RsaL | -2 | -8 | |
| MvaT, P16 subunit | 1 | -3 | |
| Carbon storage regulator | -4 | -2 | |
| LuxR family transcriptional regulator | 4 | -3 |
aProduct names for PA14 genes were obtained from the MGH-ParaBioSys:NHLBI Program for Genomic Applications, Massachusetts General Hospital and Harvard Medical School, Boston, MA (http://pga.mgh.harvard.edu; accessed 10Nov2015) [45] made available by the Pseudomonas Genome Database (http://www.pseudomonas.com/; accessed 10Nov2015) [44].
bExpression of genes within PA14 that was grown in LB broth (LB) was compared with the expression when PA14 was grown in whole blood from a healthy volunteer (HV).
cAverage of gene expression within PA14 grown in whole blood from the three severely burned patients was compared with expression when PA14 was grown in whole blood from a healthy volunteer calculated from results shown in Table 2.
Severe burn injury alters the level of blood constituents.
| Blood constituent | Normal reference range | Patient 1 | Patient 2 | Patient 3 |
|---|---|---|---|---|
| Calcium | 8.8–10.5 (mg/dL) | 8.0 | 7.5 | 8.3 |
| Hemoglobin | 13.3–17.1 (g/dL) | 18.8 | 13.3 | 13.5 |
| Phosphorus | 2.4–4.1 (mg/dL) | 2.7 | 1.6 | 2.5 |
| Albumin | 3.5–5.2 (g/dL) | 3.0 | 2.7 | 2.2 |
| Glucose | 65–115 (mg/dL) | 149 | 160 | 107 |
| Potassium | 3.5–5.1 (mmol/L) | 4.5 | 3.4 | 4.0 |
| Sodium | 136–145 (mmol/L) | 136 | 146 | 130 |
aBlood samples for these analyses were collected concurrently with blood culture samples and processed by the Clinical Laboratory at University Medical Center, Lubbock, TX.
Fig 3Color scale map of upregulated or downregulated iron acquisition genes.
Expression of genes in PA14 grown in whole blood from the three severely burned patients was compared with expression of these genes when PA14 was grown in whole blood from a healthy volunteer (control). Upregulated genes are indicated in shades of blue while downregulated genes are indicated in shades of red. Genes within operons, whether all genes of the operon are differentially expressed or not, are indicated in shades of yellow on the left. Single genes are not shaded. Operon groupings and gene product functions for PA14 genes were obtained from the MGH-ParaBioSys:NHLBI Program for Genomic Applications, Massachusetts General Hospital and Harvard Medical School, Boston, MA (http://pga.mgh.harvard.edu; accessed 10Nov2015) [45] made available by the Pseudomonas Genome Database (http://www.pseudomonas.com/; accessed 10Nov2015) [44].
Fig 4Color scale map of the T3SS genes that are either upregulated.
Expression of genes in PA14 grown in whole blood from the three severely burned patients was compared with expression of these genes when PA14 was grown in whole blood from the a healthy volunteer. Upregulated genes are indicated in shades of blue. Genes within operons, whether all genes of the operon are differentially expressed or not, are indicated in shades of yellow on the left. Single genes are not shaded. Operon groupings and functions for PA14 genes were obtained from the MGH-ParaBioSys:NHLBI Program for Genomic Applications, Massachusetts General Hospital and Harvard Medical School, Boston, MA (http://pga.mgh.harvard.edu; accessed 10Nov2015) [45] made available by the Pseudomonas Genome Database (http://www.pseudomonas.com/; accessed 10Nov2015) [44].
Fig 5Growth of PA14 in whole blood from a severely burned patient significantly enhanced expression of the T3SS genes exsA, pcrV, and popB.
RNA extracted from PA14 grown in whole blood from Patient 2 or the healthy volunteer was examined in qRT-PCR as described in Methods. Values represent the average of triplicate PCR experiments conducted on three independently obtained RNA preparations ±SEM; **P<0.01, *** P <0.001, ****P <0.0001.
Comparison of T3SS gene expression in LB broth with 5% albumin to LB Broth.
| Gene | Protein | LB broth/5% albumin:LB broth | Average of Burn Pts: Healthy volunteer |
|---|---|---|---|
| ExoT, effector protein | 2 | 5 | |
| ExoY, effector protein | 2 | 2 | |
| ExsB, T3SS regulation | 2 | 3 | |
| PcrD, translocation apparatus operon | 1 | 4 | |
| PcrG, translocation apparatus operon | 3 | 4 | |
| PcrH, translocation apparatus operon | 2 | 6 | |
| PcrV, translocation apparatus operon | 2 | 6 | |
| PopB, translocation apparatus operon | 2 | 4 | |
| PopD, translocation apparatus operon | 2 | 4 | |
| PopN, translocation apparatus operon | 2 | 3 | |
| PscB, needle complex operon | 2 | 15 | |
| PscC, needle complex operon | 2 | 17 | |
| PscD, needle complex operon | 2 | 10 | |
| PscE, needle complex operon | 2 | 5 | |
| PscF, needle complex operon | 2 | 5 | |
| PscG, needle complex operon | 1 | 6 | |
| PscH, needle complex operon | 1 | 14 | |
| PscJ, needle complex operon | 2 | 7 | |
| PscN, second needle complex operon | 2 | 3 |
aProduct names for PA14 genes were obtained from the MGH-ParaBioSys:NHLBI Program for Genomic Applications, Massachusetts General Hospital and Harvard Medical School, Boston, MA (http://pga.mgh.harvard.edu; accessed 10Nov2015) [45] made available by the Pseudomonas Genome Database (http://www.pseudomonas.com/; accessed 10Nov2015) [44].
bExpression of genes within PA14 that was grown in in LB broth with 5% albumin was compared with expression when PA14 was grown in LB broth.
cAverage of gene expression within PA14 grown in whole blood from the three severely burned patients was compared with expression when PA14 was grown in whole blood from a healthy volunteer calculated from results used to derive Fig 4.
Differentially expressed genes of the phosphate regulon (Pho).
| Gene | Product name | Pt 1 | Pt 2 | Pt 3 |
|---|---|---|---|---|
| Functional classification(s) // gene ontology terms | ||||
| Pathways // Functional prediction(s) | ||||
| -19 | -21 | -24 | ||
| Transcriptional regulators; transport of small molecules; membrane proteins // Negative-regulation of positive chemotaxis | ||||
| // Phosphate transport system regulatory protein PhoU | ||||
| -17 | -23 | -21 | ||
| Transport of small molecules // Phosphate ion transmembrane; membrane; inorganic phosphate transmembrane transport activity; phosphate ion trans-membrane ATPase activity; ATP binding | ||||
| ABC transporters // Phosphate transport system permease protein 1; ABC transporter, phosphate import, PstB; AAA+ ATPase domain | ||||
| -34 | -34 | -36 | ||
| Transport of small molecules // Phosphate ion transmembrane transport; integral component of membrane; inorganic phosphate transmembrane transport activity | ||||
| ABC transporters // Phosphate transport system permease protein PstA | ||||
| -17 | -15 | -18 | ||
| Transport of small molecules // Transport; membrane; protein binding | ||||
| ABC transporters // ABC transporter integral membrane type-1 domain profile; binding-protein-dependent transport system inner membrane component | ||||
| -45 | -48 | -57 | ||
| Transport of small molecules; no GO terms listed | ||||
| // Phosphate-selective porin O and P | ||||
| -14 | -5 | -4 | ||
| Transport of small molecules // no GO terms listed | ||||
| // Phosphate-selective porin O and P | ||||
| -9 | -10 | -13 | ||
| Transcriptional regulators; two-component regulatory systems // Phosphate ion transport; bacterial-type flagellum-dependent swarming motility; positive-regulation of cell response to phosphate starvation; phosphorelay signal transduction system; regulation of transcription, DNA-templated; phosphorelay response regulator activity, DNA binding | ||||
| Two-component system // Signal transduction response regulator, phosphate regulon transcriptional regulatory protein PhoB; signal transduction response regulator, receiver domain; winged helix-turn-helix DNA-binding domain | ||||
| -5 | -5 | -6 | ||
| Two-component regulatory systems // Regulation of transcription, DNA-templated; phosphorylation; phosphorelay signal transduction system; integral component of membrane; protein histidine kinase activity; phosphorelay sensor kinase activity; transferase activity (phosphorus-containing groups); signal transducer activity; | ||||
| Two-component systems // Signal transduction histidine kinase EnvZ-like, dimerisation/phosphoacceptor domain; Signal transduction histidine kinase, phosphate regulon sensor PhoR | ||||
| -3 | -5 | -5 | ||
| Two-component regulatory systems // Signal transduction; phosphorylation; integral component of membrane; signal transducer activity; transferase activity (phosphorus-containing groups); phosphorelay sensor kinase activity | ||||
| Two-component systems // Signal transduction histidine kinase EnvZ-like, dimerisation/phosphoacceptor domain; Signal transduction histidine kinase, homodimeric domain | ||||
| -5 | -7 | -7 | ||
| Transcriptional regulators; two-component regulatory systems // Regulation of transcription, DNA-templated; positive regulation of phospholipid biosynthetic process; phosphorelay signal transduction system; DNA binding | ||||
| -12 | -13 | -15 | ||
| Adaptation, protection; transport of small molecules; membrane proteins // integral component of membrane, cell outer membrane; lipopolysaccharide binding | ||||
| // Outer membrane protein beta-barrel domain | ||||
| 2 | 2 | 2 | ||
| Transport of small molecules; membrane proteins // Phosphate ion transport; membrane; inorganic phosphate transmembrane transport activity | ||||
| // Phosphate transporter family |
aProduct names, functional classification(s), gene ontology terms, pathways, and functional predictions for PA14 genes were obtained from the MGH-ParaBioSys:NHLBI Program for Genomic Applications, Massachusetts General Hospital and Harvard Medical School, Boston, MA (http://pga.mgh.harvard.edu; accessed 10Nov2015) [45] made available by the Pseudomonas Genome Database (http://www.pseudomonas.com/; accessed 10Nov2015) [44].
bGene expression within PA14 grown in whole blood from the three severely burned patients (Pt) was compared with expression when PA14 was grown in whole blood from a healthy volunteer.
cGenes found in operons: pstB/pstA/pstC (and related protein phoU); phoQ/phoP/oprH.